Regulatory Shifts Impacting Clinical Trials
The clinical trials landscape in Europe is undergoing significant transformation in 2025. A convergence of regulatory updates, digital harmonization, and policy realignments is shaping how biotech and health tech companies approach innovation, patient engagement, and market entry. These changes are not only improving trial transparency and efficiency but also redefining how emerging therapies make their […]